x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Mayo Clinic Cardiovascular CME

The Cardiovascular CME podcast is a free educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics.Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice.No CME credit offered for podcast episodes at this time.

education medicine

All Episodes

20:06

Role of Thrombophilia Testing in Venous Thromboembolism

Mayo Clinic Cardiovascular CME ·

2025/06/24

Role of Thrombophilia Testing in Venous ThromboembolismGuest: Ana Casanegra, M.D., M.S. Host: Kyle Klarich, M.D. Thrombophilia testing identifies inherited or acquired conditions that increase the risk of abnormal blood clotting. Sometimes it can help us guide management decisions for patients, but who and when to test are key questions to address before making this decision. Topics Discussed: What is thrombophilia, what is the difference with hypercoagulable states? Who should consider

en

08:30

Electrophysiology Considerations in Oncology Patients

Mayo Clinic Cardiovascular CME ·

2025/06/17

Electrophysiology Considerations in Oncology PatientsGuest: Nicholas Tan, M.D., M.S. Host: Anthony H. Kashou, M.D. In today’s episode of ECG Making Waves, Dr. Anthony Kashou interviews Dr. Nicholas Tan on how clinicians should consider electrophysiology in the patient with cancer. After listening to this episode, learners will understand the relationship between cancer and heart rhythm disorders, as well as begin to appreciate how cancer and arrhythmia treatments can interact. Topics

en

18:50

Chronic Total Occlusion in 2025

Mayo Clinic Cardiovascular CME ·

2025/06/10

Chronic Total Occlusion in 2025Guest: Gregory Barsness, M.D. Host: Malcolm Bell, M.D. Chronic (>3 months) complete epicardial coronary obstructive lesions, often referred to as CTOs, are recognized in a large minority of those referred for coronary angiography yet historically represent <5% of coronary intervention attempts. Improving tools, techniques and strategies have allowed greater access to percutaneous management of symptomatic coronary disease with improved procedural safety and

en

10:44

Supplements for Cardiovascular Prevention

Mayo Clinic Cardiovascular CME ·

2025/06/03

Supplements for Cardiovascular PreventionGuest: Lisa M. Gilman, APRN, C.N.P. Host: Stephen L. Kopecky, M.D. Supplement use is a growing industry in which patients seek additional potential benefit of reducing disease burden and improving overall health. This presentation will be an overview of supplements used to address cardiovascular disease prevention Topics Discussed: Our patients will often inquire if there are any supplements that would help their heart health. How do you approach

en

28:03

Role of Genetics in the Heart Failure Clinic

Mayo Clinic Cardiovascular CME ·

2025/05/27

Role of Genetics in the Heart Failure ClinicGuest: Naveen Pereira, M.D. Host: Kyle Klarich, M.D. Genetic testing for heart failure is most beneficial for patients with cardiomyopathies. It aids in personalized treatment, early diagnosis, and family risk assessment, although its uptake has been slow due to costs, access, and interpretation challenges. Ongoing research into genetic mutations and their role in cardiomyopathy pathophysiology could lead to new therapeutic targets and improved

en

10:56

Assessing Recurrence Following Pulsed Field Ablation...

Mayo Clinic Cardiovascular CME ·

2025/05/20

Assessing Recurrence Following Pulsed Field Ablation for Atrial FibrillationGuest: Nicholas Tan, M.D., M.S. Host: Anthony H. Kashou, M.D. Pulsed field ablation has been rapidly adopted across the United States since FDA approval was granted 1 year ago, due to its excellent acute efficacy, favorable safety profile, and fast workflow. However, recurrences post-ablation are comparable to that of previously established modalities, making this a significant hurdle that has yet to be overcome

en

22:59

Hybrid Procedures Collaboration with Interventional...

Mayo Clinic Cardiovascular CME ·

2025/05/13

Hybrid Procedures Collaboration with Interventional CardiologyGuest: Jason Anderson, M.D. Guest: Elizabeth Stephens, M.D., Ph.D. Host: Malcolm Bell, M.D. Increasingly, collaboration between interventional cardiology and congenital cardiac surgeons has been used to optimize care for patients with congenital heart disease. Multi-disciplinary care is key, and “hybrid” procedures can be part of that collaboration. Effective use of catheter-procedures can help decrease the number of cardiac

en

13:11

Interval Training – What Does the Science Tell Us...

Mayo Clinic Cardiovascular CME ·

2025/05/06

Interval Training – What Does the Science Tell Us About the Benefits Versus Continuous ActivityGuest: Amanda R. Bonikowske, Ph.D. Host: Stephen L. Kopecky, M.D. Learners will gain insights into the health and fitness benefits of high-intensity interval training (HIIT). They will explore various approaches to HIIT and learn strategies for integrating it into a well-rounded exercise program. Additionally, the podcast will offer a concise overview of current research on the enjoyment of HIIT and

en

11:19

Secrets to Achieving CAD Regression

Mayo Clinic Cardiovascular CME ·

2025/04/29

Secrets to Achieving CAD RegressionGuest: Stephen Kopecky, M.D. Host: Sharonne Hayes, M.D. Coronary artery disease regression can occur in lipid rich plaque. Calcified and fibrotic plaque are essentially scars and cannot regress; however, they also are not associated with plaque rupture, which can lead to myocardial infarction. Studies with invasive angiography or CT angiography that have shown successful regression of CAD have addressed risk factors including hypertension, smoking,

en

14:51

Association Between COVID-19 Vaccination and Atrial...

Mayo Clinic Cardiovascular CME ·

2025/04/22

Association Between COVID-19 Vaccination and Atrial Arrhythmias in Individuals with Cardiac Implantable Electronic DevicesGuest: Malini Madhavan, M.B.B.S. Host: Anthony H. Kashou, M.D. In a study of over 7000 individuals with a cardiac implanted device in the Biotronik CERTITUDE registry, the burden of device detected AF was noted to be higher in the 3 months after covid vaccination compared to the 3 months preceding vaccination. A similar trend was observed for Influenza vaccinated

en

14:27

Updates in Left Atrial Appendage Closure

Mayo Clinic Cardiovascular CME ·

2025/04/15

Updates in Left Atrial Appendage ClosureGuest: Ammar Killu, M.B.B.S. Host: Sharonne Hayes, M.D. In today’s episode of “Interviews With the Experts, listeners will learn how to select patients that may benefit from left atrial appendage occlusion. Listeners will understand the major differences between currently available commercial devices. Topics Discussed: What is left atrial appendage closure? Who may benefit from left atrial appendage closure and is there expansion of indications? What

en

09:35

Lifestyle Modification in the Setting of New...

Mayo Clinic Cardiovascular CME ·

2025/04/08

Lifestyle Modification in the Setting of New Prevention TherapiesGuest: R. Scott Wright, M.D. Host: Stephen L. Kopecky, M.D. Cardiovascular prevention has largely focused on new pharmaceutical therapies over the past several decades. Often overlooked are the critical roles of diet, exercise, sleep and other individual behaviors which underpin all of preventive measures for improved health. The podcast will discuss how busy clinicians can emphasize and incorporate these measures in their daily

en

19:25

Latest Developments in the Treatment of Pulmonary...

Mayo Clinic Cardiovascular CME ·

2025/04/01

Latest Developments in the Treatment of Pulmonary Arterial Hypertension Guest: Robert P. Frantz, M.D. Host: Kyle Klarich, M.D. Pulmonary arterial hypertension (PAH) is a serious disease manifested by vasoconstriction and obliteration of the pulmonary arterial vasculature resulting in rise in pulmonary artery pressure and resistance and culminating in right heart failure. Listeners will learn more about traditional treatments for PAH, as well as new anti-proliferative therapies in active

en

13:45

Exploring New Frontiers in Rhythm Monitoring Technology

Mayo Clinic Cardiovascular CME ·

2025/03/25

Exploring New Frontiers in Rhythm Monitoring TechnologyGuest: Suraj Kapa, M.D. Host: Anthony H. Kashou, M.D. After listening to this podcast, the learners will be able to confidently identify areas of advancement in cardiac rhythm monitoring. Additionally, listeners will learn specific areas of future research around technology to support the future of cardiac rhythm monitoring. Topics Discussed: What is new in technology to advance rhythm monitoring? What role is AI playing in rhythm

en

19:34

Updates from the 2024 ESC and AHA Scientific...

Mayo Clinic Cardiovascular CME ·

2025/03/18

Updates from the 2024 ESC and AHA Scientific Statements on Cardiac SarcoidosisGuest: Leslie T. Cooper Jr., M.D. Host: Kyle W. Klarich, M.D. Cardiac sarcoidosis is a systemic, chronic inflammatory disorder characterized by non-caseating, epithelioid cell granulomas that may involve many tissues and organs. The Heart Rhythm Society criteria for diagnosis of cardiac sarcoidosis require a biopsy-proven diagnosis of extra-cardiac sarcoidosis. If extra-cardiac sarcoidosis is confirmed, CS is highly

en

11:50

New RNA Therapies for Treatment of ASCVD, Prevention,...

Mayo Clinic Cardiovascular CME ·

2025/03/11

New RNA Therapies for Treatment of ASCVD, Prevention, and Dyslipidemia Guest: R. Scott Wright, M.D. Host: Stephen L. Kopecky, M.D. RNA therapies are growing in number as targeted treatments for dyslipidemia including LDL-c, Lp(a) and Triglycerides. The podcast will explore the science behind these therapies, the evidence for safety and how clinicians can utilize them in their practices. Topics Discussed: What are the new RNA therapies available or soon to be available? How are RNA based

en

14:00

Myocarditis: What’s New in 2025

Mayo Clinic Cardiovascular CME ·

2025/03/04

Myocarditis: What’s New in 2025Guest: Leslie T. Cooper Jr., M.D. Host: Kyle W. Klarich, M.D. After this episode of Mayo Clinic’s cardiovascular podcast series “Interviews With the Experts,” the listener will be able to identify the novel 2024 ACC Expert Care Decision Pathway (ECDP) 4-stage classifications of myocarditis. Hear today’s expert discuss pivotal tests in the diagnosis of myocarditis, such as cardiac magnetic resonance (CMR) imaging and endomyocardial biopsy (EMB) are considered

en

14:01

Post-Cardiac Ablation Atrial Arrhythmia Monitoring

Mayo Clinic Cardiovascular CME ·

2025/02/25

Post-Cardiac Ablation Atrial Arrhythmia Monitoring Guest: Suraj Kapa, M.D. Host: Anthony H. Kashou, M.D. In this episode of the segment "ECG Making Waves," the listener will learn to identify the right monitoring approach for a given patient’s arrhythmia considerations around ablation. They will also learn how to list specific considerations when reviewing and interpreting post-ablation arrhythmia ECGs. Topics Discussed: What specific aspects of the ECG and ECG monitoring are important to

en

12:26

Lipid Drugs: Part 2

Mayo Clinic Cardiovascular CME ·

2025/02/18

Lipid Drugs: Part 2 Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N Host: Stephen L. Kopecky, M.D. In Part 2, we will explore potential side effects and barriers to prescribing these medications, considering various patient factors. If you missed Part 1 last week, we encourage you to listen to it first, as this episode serves as a continuation and conclusion of that discussion. Topics Discussed: Side effects of these newer non-statin drugs Barriers to prescribing those drugs Connect with Mayo

en

11:15

Lipid Drugs: Part 1

Mayo Clinic Cardiovascular CME ·

2025/02/11

Lipid Drugs: Part 1Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N Host: Stephen L. Kopecky, M.D. In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available treatment options, alternative dosing schedules, and strategies for introducing newer medications. Stay tuned for Part 2, where they will examine the side effects of these newer drugs and barriers to prescribing them. Topics Discussed: What are the non-stain

en

193 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College